Currently, the use of 1 % and 2 % aqueous solutions of gentian violet (GV) is an acceptable treatment of thrush in infants. GV is generally considered efficacious; in fact, one study found GV superior to nystatin in treating thrush in infants. 1 Oral nystatin is usually prescribed as the first-line drug for this infection, while GV is commonly reserved for nystatin failures. Although GV is widely regarded as an essentially harmless medication, we present a case of GV toxicity and review the literature on this subject.
No takes yet. Share an insight, caveat, or question.
Piatt et al. (1992) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: